Free shipping on all orders over $ 500

ZK824190 

Cat. No. M29454

All AbMole products are for research use only, cannot be used for human consumption.

ZK824190  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

ZK824190 is an orally available and selective urokinase plasminogen activator (uPA) inhibitor as a potential treatment for multiple sclerosis. IC50s of 237, 1600 and 1850 nM for uPA, tPA, and Plasmin, respectively.

Chemical Information
Molecular Weight 414.4
Formula C22H20F2N2O4
CAS Number 2254001-81-3
Solubility (25°C) DMSO 250 mg/mL (ultrasonic)
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Related Serine/Threonine Protease Products
VRK-IN-1

VRK-IN-1 is a potent and selective inhibitor of vaccinia-related kinases 1 (VRK1), with an IC50 of 150 nM. VRK1 is human Ser/Thr protein kinases associated with increased cell division and neurological disorders.

HC-7366

HC-7366 is an orally bioavailable and efficacious GCN2 kinase activator.

Phe-Pro-Ala-pNA

Phe-Pro-Ala-pNA is a chromogenic substrate of tripeptidyl peptidase.

Dansyl-Glu-Gly-Arg-Chloromethylketone

Dansyl-Glu-Gly-Arg-Chloromethylketone is a protease inhibitor, and inhibits serine/threonine proteases.

Fluorescent Substrate for Subtillsin

Fluorescent Substrate for Subtillsin can be used to detect the enzyme activity of subtillsin.

  Catalog
Abmole Inhibitor Catalog




Keywords: ZK824190  supplier, Serine/Threonine Protease, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.